About 4 600 reports

Cancer Drug News 13 APRIL 2015

20 pages • By Espicom Business Intelligence

Industry Trend Analysis - Cost Of Cancer Treatment Will Continue To RiseIndustry Brief - Karyopharm Granted US Patent Covering SelinexorIndustry Brief - Longer-Term Imbruvica Data Show High Response Rates In WM PatientsIndustry Brief - FDA Grants ODD To Curis' CUDC-907 For DLBCLIndustry Brief - Astellas/MD Anderson Enter Collaboration...

825 1 114 685
Apr 2015

Anti-Infective Drug News 13 APRIL 2015

28 pages • By Espicom Business Intelligence

Industry Trend Analysis - Viable Generic Sofosbuvir Market Will Increase Pricing Pressures For GileadIndustry Brief - FDA Approves Sanofi's Quadracel DTaP-IPV Vaccine For Children Aged Four Through SixIndustry Brief - GSK To Provide Meningitis B Vaccine In UKIndustry Brief - EC Approves Kengrexal/Orbactiv/RaplixaIndustry Brief...

825 1 114 685
Apr 2015

Key Pharma News 13 APRIL 2015

24 pages • By Espicom Business Intelligence

Industry Trend Analysis - Opportunities For Vaccine Manufacturers Still Exist Despite Waning Ebola CrisisIndustry Brief - Merck KGaA/Pfizer Finalise Deal To Co-Promote XalkoriIndustry Trend Analysis - Aduro's IPO To Benefit From Novartis DealIndustry Trend Analysis - Infinity/AbbVie's Actions Indicate Confidence In Duvelisib's...

1 048 1 415 870
Apr 2015

United States Off–Label Drugs Market & Forecast

67 pages • By Renub Research

Off–label prescribing of medicines is prevalent worldwide because it gives freedom to physicians to apply new therapeutic options based on the latest evidence. Although physicians may lawfully prescribe approved Drugs for any use consistent with available scientific data and proper medical practice, but unfortunately, this is done without...

960 1 200 768
Apr 2015

Cough, Cold and Allergy (Hay Fever) Remedies in Chile

26 pages • By Euromonitor International

Current value sales of cough, cold and allergy (hay fever) remedies grew by 6% in 2014. Over the review period, it maintained its growth trend because of consumer lifestyles. Considering that medical expenses are mostly covered by consumers, they like to use cough, cold and allergy (hay fever) remedies because they provide quick relief at...

675 898 601
Apr 2015

Analgesics in Ecuador

24 pages • By Euromonitor International

During 2014, two major government regulations affected sales of analgesics. In December 2013, the COMEX (External Commerce Committee, in Spanish), implemented Resolution 116. The aim of the resolution is supposedly to control product quality by demanding importers obtain quality certificates approved by the INEN (Norms Institute in Spanish)....

675 898 601
Apr 2015

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

33 pages • By Euromonitor International

Cough, cold and allergy (hay fever) remedies posted current value growth of 1% in 2014. Medicated confectionery accounted for almost half of the category’s value sales. Other categories saw a decline in growth rate but the slow value growth of medicated confectionery had the greatest impact on wider category growth.Euromonitor International's...

675 898 601
Apr 2015

Digestive Remedies in Ecuador

21 pages • By Euromonitor International

New government controls are affecting sales. The COMEX (External Commerce Committee in Spanish) introduced import barriers in December 2013, supposedly to improve quality controls, which affect finished products and raw materials. Another important control introduced in July 2014 was the Price Establishment for Medicine of Human Use and Consumption...

675 898 601
Apr 2015

Laboratorios Industriales Farmaceuticos Ecuatorianos Life CA in Consumer Health (Ecuador)

2 pages • By Euromonitor International

LIFE’s main objective is to continue leading the Ecuadorian market as the largest unit producer of medicines. It constantly develops new products and invests in research and development. The firm aims to be known as a company that provides physical, emotional and psychological well-being.Euromonitor International Local Company Profiles...

115 153 102
Apr 2015

Dermatologicals in Ecuador

20 pages • By Euromonitor International

Changes in government requirements affected the category. The COMEX (External Commerce Committee in Spanish) introduced import barriers in December 2013, supposedly to improve quality controls, which affect finished products and raw materials. Another important control introduced in July 2014 was the Price Establishment for Medicine of Human...

675 898 601
Apr 2015

Boehringer Ingelheim del Ecuador Cía Ltda in Consumer Health (Ecuador)

2 pages • By Euromonitor International

The company aims to maintain its leadership in vitamins and dietary supplements by continuously supporting its products with marketing activities.Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background...

115 153 102
Apr 2015

Laboratorio Maver Ltda in Consumer Health (Chile)

2 pages • By Euromonitor International

Laboratorio Maver will continue to focus on expanding the consumer base of its brands Tapsín and Disfruta over the forecast period via investment in promotional activities and the revamping of its product range. Whilst the company specialises in OTC healthcare, it also offers Rx, cosmetic and dental supply products. Laboratorio Maver is also...

115 153 102
Apr 2015

Cough, Cold and Allergy (Hay Fever) Remedies in Ecuador

22 pages • By Euromonitor International

The government is becoming more controlling. It wants to reduce imports by US$6 billion by 2017. To this end it introduced created Resolution 116 through the COMEX (External Commerce Committee, in Spanish), which creates quality controls and entrance barriers for most imported products, including raw materials. This affects the imported brands...

675 898 601
Apr 2015

Consumer Health in Ecuador

66 pages • By Euromonitor International

Overall growth in consumer health in Ecuador in 2014 was slower than over the review period. The various industry changes due to government regulations – import barriers and price controls – took most companies by surprise.Euromonitor International's Consumer Health in Ecuador report offers a comprehensive guide to the size and shape...

1 800 2 394 1 602
Apr 2015

Consumer Health in the Netherlands

99 pages • By Euromonitor International

In 2014, consumer health in the Netherlands posted slightly stronger current value growth than in 2013 but a weaker performance than the review period CAGR. Uncertain economic conditions contributed to this performance as both the employment rate and consumer confidence in the country are still recovering. The consumer health industry was...

1 800 2 394 1 602
Apr 2015

Cardiometabolic Drug News APRIL 2015

19 pages • By Espicom Business Intelligence

Industry Trend Analysis - Mysimba Will Have Fewer Competitors But Sales Dampened By Safety ConcernsIndustry Brief - Intarcia/Numab Collaborate To Develop Therapies In Multiple IndicationsIndustry Brief - Janssen Acquires XO1Industry Brief - Cardio3 To Open Manufacturing Facility In MinnesotaIndustry Brief - Saxenda Approved...

825 1 114 685
Apr 2015

NRT Smoking Cessation Aids in Sweden

29 pages • By Euromonitor International

E-cigarettes, a product category which saw explosive growth lately, are in many ways a threat to NRT smoking cessation aids as they represent a potential substitute product. Both consumers as well as many marketers of e-cigarettes consider e-cigarettes, at least to a degree, as a form of smoking cessation aid. The ruling by a Swedish administrative...

675 898 601
Apr 2015

Consumer Health in Sweden

117 pages • By Euromonitor International

In 2014, consumer health saw healthy growth in retail value sales terms. This growth, however, was not evenly distributed across the consumer health categories. There were deviations from this relatively stable and healthy aggregate trend, with categories exhibiting both substantial negative growth rates as well as explosive positive growth....

1 800 2 394 1 602
Apr 2015

Analgesics in Sweden

33 pages • By Euromonitor International

The Medical Products Agency proposed that all sales of acetaminophen are to be banned effective as of March 2015, citing a greater than usual influx of distressed callers to emergency hotlines who had purportedly overdosed on acetaminophen products. Sales outside of pharmacies represented 36% of all total sales of acetaminophen in 2013. A...

675 898 601
Apr 2015

Cough, Cold and Allergy (Hay Fever) Remedies in Sweden

35 pages • By Euromonitor International

Sinupret, a product intended to treat the symptoms and causes of rhinitis and inflammation of paranasal sinuses, was launched by Bringwell during 2014 in order to hopefully mimic the sales of former top selling product Sinova from Bionorica that was taken off the market in 2013. While the product has yet to reach such formidable levels of...

675 898 601
Apr 2015

McNeil Sweden AB in Consumer Health (Sweden)

3 pages • By Euromonitor International

McNeil Sweden AB is expected to continue emphasising its strong brands by focusing on marketing and developing solid distribution and innovative products. One of its strongest brands, Nicorette, will continue to enable it to have a competitive advantage, especially outside the pharmacy channel. The brand is leveraged through a wide product...

115 153 102
Apr 2015

CNS Drug News 30 MARCH 2015

16 pages • By Espicom Business Intelligence

Industry Trend Analysis - Dementia Research To See Increased InvestmentIndustry Brief - Opicapone Significantly Improves Off Time In Fluctuating PD Patients As Add-On To LevodopaIndustry Brief - AbbVie/C2N Enter Worldwide Licence Agreement For AD TherapyIndustry Brief - Novartis Buys Out CAD106 Licence Agreement For CHF4mnIndustry...

825 1 114 685
Apr 2015

World Generic Markets 30 MARCH 2015

24 pages • By Espicom Business Intelligence

Industry Trend Analysis - Sun/Ranbaxy Merger Will Create New Global Generics MajorIndustry Brief - Apotex Realigns Structure And Operating ModelIndustry Brief - TWi Initiates First Shipments To USIndustry Brief - InSite Settles Azithromycin Litigation With MylanIndustry Brief - Aurobindo Gains Lacosamide Tentative ApprovalIndustry...

825 1 114 685
Apr 2015

Consumer Health in Costa Rica

76 pages • By Euromonitor International

Despite the ongoing economic uncertainty in Costa Rica in 2014, consumer health showed good growth. The rising awareness of self-care and healthy lifestyles, in combination with sports participation and prevention, contributed to the sustained growth of a number of categories, such as vitamins and dietary supplements. Other categories, such...

1 800 2 394 1 602
Apr 2015

Digestive Remedies in Costa Rica

23 pages • By Euromonitor International

Digestive problems continued to represent one of the main health concerns in the country in 2014, as a consequence of different intensifying factors, such as stress (due to the increasing cost of life and economic pressure), food allergies (gluten, lactose), bad eating habits, fast food and packaged food prevalence and extended neglect, amongst...

675 898 601
Apr 2015

Cough, Cold and Allergy (Hay Fever) Remedies in Costa Rica

23 pages • By Euromonitor International

The further proliferation of new bacteria and virus strains in combination with other prevailing factors, such as fluctuating climate conditions, stressful lifestyles, pollution, antibiotics abuse and prolonged sun exposure, are certainly impacting the latest innovation efforts within cough, cold and allergy remedies. New emerging symptoms...

675 898 601
Apr 2015

Analgesics in Costa Rica

22 pages • By Euromonitor International

Stress symptoms are remarkably affecting the local population’s health as the pace of modern life is become faster and more demanding. Consequently, muscle relaxants (which are also demanded for their sleeping properties) are becoming irreplaceable items amongst an increasing base of consumers, for which insomnia, strains, sprains, back pain...

675 898 601
Apr 2015

Contraception Manufacturers Global - Industry Report

50 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s CONTRACEPTION MANUFACTURERS (Global) analysis is the most definitive and accurate study of the CONTRACEPTION MANUFACTURERS (Global) sector in 2013.The report is split into two sections and uses both a written and graphical analysis – analysing the 50 largest CONTRACEPTION MANUFACTURERS (Global) companies. The CONTRACEPTION...

1 150 1 668 1 035
Apr 2015

Antibiotic Manufacturers Global - Industry Report

150 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s ANTIBIOTIC MANUFACTURERS (Global) analysis is the most definitive and accurate study of the ANTIBIOTIC MANUFACTURERS (Global) sector in 2013.The report is split into two sections and uses both a written and graphical analysis – analysing the 150 largest ANTIBIOTIC MANUFACTURERS (Global) companies. The ANTIBIOTIC...

1 150 1 668 1 035
Apr 2015

Testosterone acetate Chemical Report

By PureData

Testosterone acetate Chemical ReportThis Testosterone acetate Chemical World Consumption Reportt provides data on the net consumption of Testosterone acetate in each of the countries listed. The substance covered (Testosterone acetate) are classified by the Chemical Registry, EC, EU, CAS, or other coding system. In addition, where...

3 688 4 609 2 950
Apr 2015